open access

Vol 74, No 6 (2023)
Review paper
Submitted: 2023-08-22
Accepted: 2023-10-01
Published online: 2023-11-20
Get Citation

Thyroid nodule core needle biopsy — current approach

Emrah Karatay1, Mirkhalig Javadov2, Hatice Kaya3
·
Pubmed: 37994586
·
Endokrynol Pol 2023;74(6).
Affiliations
  1. Department of Radiology, Ministry of Health Tuzla State Hospital, Istanbul, Türkiye
  2. Department of General Surgery, Medicana International Atasehir Hospital, Atasehir, Istanbul, Türkiye
  3. Department of Radiology, Ministry of Health Taksim Training and Research Hospital, Taksim, Beyoğlu, Istanbul, Türkiye

open access

Vol 74, No 6 (2023)
Review Article
Submitted: 2023-08-22
Accepted: 2023-10-01
Published online: 2023-11-20

Abstract

Fine needle aspiration biopsy (FNAB) guided by ultrasonography is routinely used to identify thyroid nodules prior to surgery. Although FNAB has great diagnostic accuracy and safety, it is limited by its relatively low diagnostic accuracy in follicular lesions, such as non-diagnostic or atypia of unclear significance (AUS)/follicular lesion of uncertain significance (FLUS). Additional diagnostic tests are required to overcome these challenges in evaluating thyroid nodules. Thyroid nodules can now be diagnosed with spring-activated single- or double-action needles following the introduction of core needle biopsy (CNB). CNB has the ability to address the limitations of FNAB by obtaining a sizeable tissue sample with more details on the histological structure supporting the capsule and fewer non-diagnostic effects brought on by the absence of follicular cells. Compared to repeated FNAB, CNB has been demonstrated to produce fewer ambiguous results, such as non-diagnostic or AUS/FLUS results. The Korean Endocrine Pathology Thyroid CNB Working Group issued its first set of guidelines for “Pathology Reporting of Thyroid Core Needle Biopsy” in 2015. In 2017, the Korean Society of Thyroid Radiology (KSThR) published “Core Needle Biopsy of Thyroid: 2016 Consensus Statement and Recommendations from the Korean Society of Thyroid Radiology”. The main objectives of thyroid CNB are to detect individuals with thyroid illness who require surgery and to obtain a significant number of thyroid lesions with low morbidity.

Abstract

Fine needle aspiration biopsy (FNAB) guided by ultrasonography is routinely used to identify thyroid nodules prior to surgery. Although FNAB has great diagnostic accuracy and safety, it is limited by its relatively low diagnostic accuracy in follicular lesions, such as non-diagnostic or atypia of unclear significance (AUS)/follicular lesion of uncertain significance (FLUS). Additional diagnostic tests are required to overcome these challenges in evaluating thyroid nodules. Thyroid nodules can now be diagnosed with spring-activated single- or double-action needles following the introduction of core needle biopsy (CNB). CNB has the ability to address the limitations of FNAB by obtaining a sizeable tissue sample with more details on the histological structure supporting the capsule and fewer non-diagnostic effects brought on by the absence of follicular cells. Compared to repeated FNAB, CNB has been demonstrated to produce fewer ambiguous results, such as non-diagnostic or AUS/FLUS results. The Korean Endocrine Pathology Thyroid CNB Working Group issued its first set of guidelines for “Pathology Reporting of Thyroid Core Needle Biopsy” in 2015. In 2017, the Korean Society of Thyroid Radiology (KSThR) published “Core Needle Biopsy of Thyroid: 2016 Consensus Statement and Recommendations from the Korean Society of Thyroid Radiology”. The main objectives of thyroid CNB are to detect individuals with thyroid illness who require surgery and to obtain a significant number of thyroid lesions with low morbidity.

Get Citation

Keywords

thyroid nodule; core needle biopsy; FNAB; ultrasound

About this article
Title

Thyroid nodule core needle biopsy — current approach

Journal

Endokrynologia Polska

Issue

Vol 74, No 6 (2023)

Article type

Review paper

Published online

2023-11-20

Page views

609

Article views/downloads

239

DOI

10.5603/ep.97053

Pubmed

37994586

Bibliographic record

Endokrynol Pol 2023;74(6).

Keywords

thyroid nodule
core needle biopsy
FNAB
ultrasound

Authors

Emrah Karatay
Mirkhalig Javadov
Hatice Kaya

References (37)
  1. Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2017; 27(11): 1341–1346.
  2. Ha EJu, Lim HK, Yoon JH, et al. Korean Society of Thyroid Radiology (KSThR) and Korean Society of Radiology. Primary Imaging Test and Appropriate Biopsy Methods for Thyroid Nodules: Guidelines by Korean Society of Radiology and National Evidence-Based Healthcare Collaborating Agency. Korean J Radiol. 2018; 19(4): 623–631.
  3. Bongiovanni M, Spitale A, Faquin WC, et al. The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis. Acta Cytol. 2012; 56(4): 333–339.
  4. Yoo C, Choi HJ, Im S, et al. Fine needle aspiration cytology of thyroid follicular neoplasm: cytohistologic correlation and accuracy. Korean J Pathol. 2013; 47(1): 61–66.
  5. Novoa E, Gürtler N, Arnoux A, et al. Role of ultrasound-guided core-needle biopsy in the assessment of head and neck lesions: a meta-analysis and systematic review of the literature. Head Neck. 2012; 34(10): 1497–1503.
  6. Ha EJu, Baek JH, Lee JH, et al. Complications following US-guided core-needle biopsy for thyroid lesions: a retrospective study of 6,169 consecutive patients with 6,687 thyroid nodules. Eur Radiol. 2017; 27(3): 1186–1194.
  7. Paja M, Del Cura JL, Zabala R, et al. Core-needle biopsy in thyroid nodules: performance, accuracy, and complications. Eur Radiol. 2019; 29(9): 4889–4896.
  8. Cao H, Kao RH, Hsieh MC. Comparison of core-needle biopsy and fine-needle aspiration in screening for thyroid malignancy: a systematic review and meta-analysis. Curr Med Res Opin. 2016; 32(7): 1291–1301.
  9. Suh CH, Baek JH, Choi YJ, et al. Efficacy and safety of core-needle biopsy in initially detected thyroid nodules via propensity score analysis. Sci Rep. 2017; 7(1): 8242.
  10. Hong MJi, Na DG, Kim SJ, et al. Role of core needle biopsy as a first-line diagnostic tool for thyroid nodules: a retrospective cohort study. Ultrasonography. 2018; 37(3): 244–253.
  11. Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. J Am Soc Cytopathol. 2017; 6(6): 217–222.
  12. Jung CK, Min HS, Park HJ, et al. Korean Endocrine Pathology Thyroid Core Needle Biopsy Study Group. Pathology Reporting of Thyroid Core Needle Biopsy: A Proposal of the Korean Endocrine Pathology Thyroid Core Needle Biopsy Study Group. J Pathol Transl Med. 2015; 49(4): 288–299.
  13. Na DG, Baek JH, Jung SoL, et al. Korean Society of Thyroid Radiology (KSThR) and Korean Society of Radiology. Core Needle Biopsy of the Thyroid: 2016 Consensus Statement and Recommendations from Korean Society of Thyroid Radiology. Korean J Radiol. 2017; 18(1): 217–237.
  14. Jung CK, Baek JH, Na DG, et al. 2019 Practice guidelines for thyroid core needle biopsy: a report of the Clinical Practice Guidelines Development Committee of the Korean Thyroid Association. J Pathol Transl Med. 2020; 54(1): 64–86.
  15. Choi YJ, Baek JH, Suh CH, et al. Core-needle biopsy versus repeat fine-needle aspiration for thyroid nodules initially read as atypia/follicular lesion of undetermined significance. Head Neck. 2017; 39(2): 361–369.
  16. Baloch ZW, Cibas ES, Clark DP, et al. The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation. Cytojournal. 2008; 5: 6.
  17. Gharib H, Papini E, Garber JR, et al. AACE/ACE/AME Task Force on Thyroid Nodules. American Association Of Clinical Endocrinologists, American College Of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines For Clinical Practice For The Diagnosis and Management Of Thyroid Nodules — 2016 Update. Endocr Pract. 2016; 22(5): 622–639.
  18. Jarząb B, Dedecjus M, Lewiński A, et al. Diagnosis and treatment of thyroid cancer in adult patients - Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych - Rekomendacje Polskich Towarzystw Naukowych oraz Narodowej Strategii Onkologicznej. Aktualizacja na rok 2022]. Endokrynol Pol. 2022; 73(2): 173–300.
  19. Na DG, Kim Jh, Sung JY, et al. Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology. Thyroid. 2012; 22(5): 468–475.
  20. Baek JH. Current status of core needle biopsy of the thyroid. Ultrasonography. 2017; 36(2): 83–85.
  21. Park KT, Ahn SH, Mo JH, et al. Role of core needle biopsy and ultrasonographic finding in management of indeterminate thyroid nodules. Head Neck. 2011; 33(2): 160–165.
  22. López JI, Zabala R, Del Cura JL. Histological diagnosis of thyroid disease using ultrasound-guided core biopsies. Eur Thyroid J. 2013; 2(1): 29–36.
  23. Hahn SY, Shin JH, Oh YL. What Is the Ideal Core Number for Ultrasonography-Guided Thyroid Biopsy of Cytologically Inconclusive Nodules? AJNR Am J Neuroradiol. 2017; 38(4): 777–781.
  24. Suh CH, Baek JH, Lee JH, et al. The Role of Core-Needle Biopsy as a First-Line Diagnostic Tool for Initially Detected Thyroid Nodules. Thyroid. 2016; 26(3): 395–403.
  25. Chung SR, Baek JH, Choi YJ, et al. The Role of Core Needle Biopsy for the Evaluation of Thyroid Nodules with Suspicious Ultrasound Features. Korean J Radiol. 2019; 20(1): 158–165.
  26. Jeong EJi, Chung SR, Baek JH, et al. A Comparison of Ultrasound-Guided Fine Needle Aspiration versus Core Needle Biopsy for Thyroid Nodules: Pain, Tolerability, and Complications. Endocrinol Metab (Seoul). 2018; 33(1): 114–120.
  27. Jin Kim H, Koon Kim Y, Hoon Moon J, et al. Thyroid core needle biopsy: patients' pain and satisfaction compared to fine needle aspiration. Endocrine. 2019; 65(2): 365–370.
  28. Harvey JN, Parker D, De P, et al. Sonographically guided core biopsy in the assessment of thyroid nodules. J Clin Ultrasound. 2005; 33(2): 57–62.
  29. Bergeron M, Beaudoin D. Simple core-needle biopsy for thyroid nodule, complicated tinnitus. Eur Thyroid J. 2014; 3(2): 130–133.
  30. Shah KSV, Ethunandan M. Tumour seeding after fine-needle aspiration and core biopsy of the head and neck--a systematic review. Br J Oral Maxillofac Surg. 2016; 54(3): 260–265.
  31. Thavarajah R, Mudimbaimannar VK, Elizabeth J, et al. Chemical and physical basics of routine formaldehyde fixation. J Oral Maxillofac Pathol. 2012; 16(3): 400–405.
  32. Hewitt SM, Lewis FA, Cao Y, et al. Tissue handling and specimen preparation in surgical pathology: issues concerning the recovery of nucleic acids from formalin-fixed, paraffin-embedded tissue. Arch Pathol Lab Med. 2008; 132(12): 1929–1935.
  33. Xiong Y, Yan L, Nong L, et al. Pathological diagnosis of thyroid nodules based on core needle biopsies: comparative study between core needle biopsies and resected specimens in 578 cases. Diagn Pathol. 2019; 14(1): 10.
  34. Ren J, Baek JH, Chung SR, et al. Degenerating Thyroid Nodules: Ultrasound Diagnosis, Clinical Significance, and Management. Korean J Radiol. 2019; 20(6): 947–955.
  35. Basolo F, Macerola E, Poma AM, et al. The 5 edition of WHO classification of tumors of endocrine organs: changes in the diagnosis of follicular-derived thyroid carcinoma. Endocrine. 2023; 80(3): 470–476.
  36. Alshenawy HA. Utility of immunohistochemical markers in diagnosis of follicular cell derived thyroid lesions. Pathol Oncol Res. 2014; 20(4): 819–828.
  37. Crescenzi A, Guidobaldi L, Nasrollah N, et al. Immunohistochemistry for BRAF(V600E) antibody VE1 performed in core needle biopsy samples identifies mutated papillary thyroid cancers. Horm Metab Res. 2014; 46(5): 370–374.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl